Healthcare provider profile · identity verified

Immanuel Amissah, MD

Family Practice · NEW PORT RICHEY, FL · NPI 1114066115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	139
Amlodipine Besylate	Amlodipine Besylate	398	129
Lisinopril	Lisinopril	343	104
Levothyroxine Sodium	Levothyroxine Sodium	272	94
Gabapentin	Gabapentin	258	73
Albuterol Sulfate Hfa	Albuterol Sulfate	247	86
Rosuvastatin Calcium	Rosuvastatin Calcium	246	81
Tamsulosin Hcl	Tamsulosin Hcl	217	69
Metoprolol Succinate	Metoprolol Succinate	216	69
Pantoprazole Sodium	Pantoprazole Sodium	216	67
Omeprazole	Omeprazole	207	62
Losartan Potassium	Losartan Potassium	202	66
Trazodone Hcl	Trazodone Hcl	179	58
Furosemide	Furosemide	174	62
Simvastatin	Simvastatin	169	57
Alprazolam	Alprazolam	163	34
Metoprolol Tartrate	Metoprolol Tartrate	163	56
Clopidogrel	Clopidogrel Bisulfate	157	53
Zolpidem Tartrate	Zolpidem Tartrate	153	27
Glimepiride	Glimepiride	140	49
Tizanidine Hcl	Tizanidine Hcl	140	44
Metformin Hcl	Metformin Hcl	134	47
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	127	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	125	21
Montelukast Sodium	Montelukast Sodium	119	44
Lorazepam	Lorazepam	111	19
Prednisone	Prednisone	108	75
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	21
Metformin Hcl Er	Metformin Hcl	101	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	100	17
Tramadol Hcl	Tramadol Hcl	93	29
Allopurinol	Allopurinol	92	29
Jardiance	Empagliflozin	89	23
Potassium Chloride	Potassium Chloride	89	32
Sertraline Hcl	Sertraline Hcl	87	27
Carvedilol	Carvedilol	81	26
Fluticasone Propionate	Fluticasone Propionate	81	45
Famotidine	Famotidine	80	28
Oxycodone Hcl	Oxycodone Hcl	79	12
Torsemide	Torsemide	78	32
Hydrochlorothiazide	Hydrochlorothiazide	77	27
Ibuprofen	Ibuprofen	77	34
Azithromycin	Azithromycin	74	63
Eliquis	Apixaban	74	26
Pravastatin Sodium	Pravastatin Sodium	71	20
Escitalopram Oxalate	Escitalopram Oxalate	65	17
Clonazepam	Clonazepam	64	15
Ozempic	Semaglutide	62	11
Meloxicam	Meloxicam	60	21
Diclofenac Sodium	Diclofenac Sodium	59	17
Duloxetine Hcl	Duloxetine Hcl	59	19
Buspirone Hcl	Buspirone Hcl	57	18
Symbicort	Budesonide/Formoterol Fumarate	55	19
Acetaminophen-Codeine	Acetaminophen With Codeine	54	16
Trulicity	Dulaglutide	53	11
Dicyclomine Hcl	Dicyclomine Hcl	49	16
Atenolol	Atenolol	47	17
Celecoxib	Celecoxib	47	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	47	suppressed
Ezetimibe	Ezetimibe	47	18
Finasteride	Finasteride	47	16
Meclizine Hcl	Meclizine Hcl	45	16
Pregabalin	Pregabalin	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	44	15
Hydroxyzine Hcl	Hydroxyzine Hcl	43	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	35
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	20
Humalog Kwikpen U-100	Insulin Lispro	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	24
Calcitriol	Calcitriol	38	suppressed
Methylprednisolone	Methylprednisolone	38	33
Paroxetine Hcl	Paroxetine Hcl	38	13
Temazepam	Temazepam	38	suppressed
Glipizide	Glipizide	37	11
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	36	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	16
Doxycycline Monohydrate	Doxycycline Monohydrate	35	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	14
Lovastatin	Lovastatin	35	11
Spironolactone	Spironolactone	35	13
Hydralazine Hcl	Hydralazine Hcl	34	15
Warfarin Sodium	Warfarin Sodium	34	12
Nitroglycerin	Nitroglycerin	33	15
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	13
Levetiracetam	Levetiracetam	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	29
Testosterone Cypionate	Testosterone Cypionate	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Cefuroxime	Cefuroxime Axetil	28	24
Mirtazapine	Mirtazapine	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Jantoven	Warfarin Sodium	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Indomethacin	Indomethacin	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Levofloxacin	Levofloxacin	20	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Mupirocin	Mupirocin	20	17
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Lactulose	Lactulose	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Xarelto	Rivaroxaban	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Baclofen	Baclofen	16	suppressed
Digoxin	Digoxin	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fluconazole	Fluconazole	16	13
Gemfibrozil	Gemfibrozil	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Primidone	Primidone	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Valsartan	Valsartan	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Diazepam	Diazepam	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error